EQT Logo

Divestments

Arvelle Therapeutics

Dutch biotech company commercializing an epilepsy drug with unprecedented efficacy for refractory patients with partial onset seizures.

Key Facts
Sector

Life Sciences

Country

Netherlands

Fund

LSP 6

Entry

2019

Exit

2021

Do You Want to Know More?

We are eager to explore how we can achieve great things together.